Article Listing - Patient groups take issue with the UK NICE’s reassessment of switching on RA drugs and decision on leukemia therapy azacitidine

PROMOTIONS AT MERCK & CO

27 April 1992

At world drug leader Merck & Co, Louis Sherwood has been named senior vice president of medical and scientific affairs....

APPOINTMENTS AT US NAAIDC

27 April 1992

US Health and Human Services Secretary Louis Sullivan has announced five appointments to the National Advisory Allergy and Infectious Diseases...

RETROVIR & PATIENT SURVIVAL

27 April 1992

A study published in the New England Journal of Medicine has found that early treatment with Wellcome's Retrovir (zidovudine) before...

EPHMRA MEETING

27 April 1992

The 31st European Pharmaceutical Market Research Association members conference will take place in Lyon, France, from June 3 to June...

MERCK & MERIEUX VACCINE DEAL

27 April 1992

Merck & Co and Institut Merieux have agreed to collaborate in developing and marketing single-injection vaccines directed against several childhood...

METHOTREXATE IN JUVENILE ARTHRITIS

27 April 1992

Methotrexate is known to be effective in adults with severe rheumatoid arthritis, but there has been a lack of data...

LIMITED US APPROVAL RECOMMENDED FOR HIVID

27 April 1992

Following closely on from the first full approval of the product in Austria (Marketletter April 20), an advisory panel to...

SB WINS QUEEN'S AWARD FOR BACTROBAN

27 April 1992

In the UK, SmithKline Beecham has won a 1992 Queen's award for technology for its topical antibiotic Bactroban (mupirocin), which...

ISIS ACQUIRES PNA OLIGOMER RIGHTS

27 April 1992

The antisense oligonucleotide specialist Isis Pharmaceuticals has signed a research and development agreement with investigators at the Panum Institute of...

BELARUS DRUG PRICE INCREASE

27 April 1992

The government of Belorussia in the Commonwealth of Independent States has announced that prices of medicines will increase two-fold, the...

Showing 94141-94150 of 95329 articles